Wei (William) Cao, PhDFounder, Chairman and CEO at Gracell Biotechnologies Group
Dr. Wei (William) Cao is the founder, chairman and CEO of Gracell Biotechnologies Group. Through external partnership and in-house R&D effort, Gracell has been rapidly progressing with novel CAR-T programs and regenet stove medicine programs. Dr. Cao has over 30 years of professional experience in scientific research, products development and startups. He was the co-founder and CEO of a Nasdaq listed cellular therapy company. Prior to his ventures, Dr Cao served as Technical Manager for Bayer Asia Pacific, and China General Manager of Affymetrix, a world leader in genetic analysis. Dr. Cao earned a Bachelor’s degree in Medicine from Fudan University and a PhD degree in Immuno-Pharmacology from Medical College of Virginia. He has extensive research experience in immune-pharmacology field at Harvard Medical School and Stanford University Medical Center. He is the inventor of more than 70 patents in the field of stem cell and CAR-T technologies.